Akesobio kicks off virtual roadshow for HK IPO

By Jonathan Breen
14 Apr 2020

Akesobio, a Chinese biopharmaceutical firm, has launched an online-only roadshow for its up to HK$2.58bn ($332.9m) IPO amid numerous country-wide lockdowns globally to combat the Covid-19 coronavirus pandemic.

A seven-strong syndicate began taking orders for the trade on Tuesday morning in Hong Kong. To navigate the restrictions on face-to-face contact caused by the coronavirus, bookbuilding is being conducted entirely through video conference calls, said a source close to the deal.

“There were physical meetings at the ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial